October 2024 brought 4 new FDA drug approvals in the oncology space. With new drug regimens in both the solid tumor and blood ...

While pregnancy-associated cancer risks increased with age, breast cancer during pregnancy tended to not impact obstetric ...

The FDA granted an accelerated approval to asciminib for newly diagnosed Ph+ chronic myeloid leukemia in the chronic phase.

An expert discussed fam-trastuzumab deruxtecan-nxki for HER2-mutant and -overexpressing non-small cell lung cancer.

Advanced practice providers discuss the second-line use of elacestrant in patients with co-mutated, ER+, HER2—advanced or ...

A nurse practitioner discusses ASCO’s recommendations of CDK4/6 inhibitors—namely abemaciclib and ribociclib—in certain ...

Research is analyzing the effect of imtermittent fasting on quality of life outcomes in patients undergoing radiation therapy.

The FDA expanded the approval of methotrexate to include patients with pediatric acute lymphoblastic leukemia and polyarticular juvenile idiopathic arthritis. The FDA approval of methotrexate (Jylamvo ...

“You can control where you focus your attention,” said Anne M. Reb, PhD, NP, who recently presented on a nurse-led ...

Early Symptom Detection and the Impact on Patient Outcomes in GVHD ...